MMD 1/27: Neurogenesis and Stem Cell Applications in Neurology
Stem Cells and Neurogenesis in Neurological Disorders
Application of Stem Cells:
Stem cells can be utilized to counteract neurodegeneration in various neurological disorders, including Alzheimer’s disease.
Example discussed includes comparing normal brain cells to those affected by Alzheimer’s, highlighting cell loss in affected areas.
Therapeutic Strategies:
A therapeutic strategy involves stimulating neurogenesis in areas where cells have degenerated.
Goal: Replace lost neurons with newly generated cells to fill empty areas of the brain.
This requires the injection of genes into specific brain areas to stimulate neurogenesis.
Challenges in Neurogenesis:
Regenerated cells (neurons) must integrate properly:
Need to develop axons and synapses appropriately.
Must reach correct functional areas to ensure viability and utility in treatment.
Past research shows promise with animal models, but results do not translate effectively to human applications.
Factors in Neurodegeneration Treatment:
In addition to cell count, differentiation status is critical for developing effective treatment strategies for neurodegeneration.
This emphasizes the need for successful recruitment of new cells into the damaged areas.
Visual modifications to existing tissues can allow for amplification and direct injection of cultured cells into damaged areas without needing recruitment.
Neurogenic Niches:
Neurogenic areas are regions in the brain such as the hippocampus and the ventricular zone that are vital for neurogenesis.
Cells can be stimulated to migrate to these niches for regeneration purposes.
Neuronal Development Stages:
Neurogenesis: Initial stem cell proliferation phase.
Neuronal Migration: New neurons migrate to their designated final destinations in the brain.
Synapse Formation: Final stage where new neurons form synapses to connect with existing neural networks.
Types of Neuronal Migration:
Radial Migration:
Neurons originating from the ventricular zone move radially to their final location, typically resulting in excitatory pyramidal neurons.
Tangential Migration:
Neurons migrate horizontally from regions such as the medial and lateral ganglionic eminences, often resulting in inhibitory interneurons.
Layering in Neurons:
The developing brain consists of six layers:
Layers 1 and 2 contain newer cells.
Layers 5 and 6 are older cells, demonstrating a unique inside-out position during and following radial migration.
Excitation/Inhibition Balance (EI Balance):
Essential for proper brain function:
Pyramidal neurons (excitatory) and interneurons (inhibitory) maintain this balance.
Imbalances can lead to neurodevelopmental or psychiatric conditions.
Neuronal Migration Mechanism:
Neurons extend a leading process that guides migration, supported by a central zone that carries the nucleus.
Proteins like Myosin play a role in this migration process. Any mutation affecting these proteins can compromise neuronal migration, which can lead to developmental disorders.
Impact of Migration Defects:
Defective migration can lead to conditions such as autism, intellectual disabilities, schizophrenia, and cerebral palsy due to disrupted connectivity among neurons.
Neuronal Structure and Health:
Unique structural arrangements support functional neuronal connectivity.
Columnar structures in the brain relate to connectivity, and disruption is seen in various pathologies, including autism and Alzheimer’s.
Postnatal Brain Development and Migration:
Although migration primarily occurs pre-birth, some limited postnatal migration and neurogenesis can occur, especially in the hippocampus for adults.
Evidence shows significant migration in infant brains, but postnatal migration is generally restrictive.
Experimental Evidence:
Studies illustrate precise mechanisms of migration and the resulting structural features, shedding light on the importance of specific genes and proteins that guide migration processes.
Issues like LIS1 gene mutations result in disrupted neuronal migration, causing significant structural and functional brain disorders.